ARCHIVES

Tykerb And Trastuzumab Showed Increase In PFS For HER2+ Breast Cancer In Study

This article is from The Cancer Letter archive.

Vol. 31 No. 5 | May 30, 2008

Download PDF Visit The Full Archive

Related Articles

No Proof Fiber Is Anticarcinogenic, Newell Says, But diet should Include Anyway

May 18, 1979

DCBD Board Approves Concept for Astrocytoma Molecular Probes

July 22, 1988

Nature Editorial Criticizes NCI PR Spending

March 15, 2013

Steven Woolf: Why CMS Should Not Cover LDCT

May 9, 2014

In Brief: Hospices Urges To Develop Program For AIDs Victims; Companies Give $25,5000 To NCI Fund

November 1, 1985

Scientists, Industry Identify Barriers To Development of Molecular Therapies

April 12, 2002